世界の核内受容体ROR-ガンマ市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC07140)
◆英語タイトル:Global Nuclear Receptor ROR-Gamma Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC07140
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、核内受容体ROR-ガンマの世界市場を調査対象にし、核内受容体ROR-ガンマの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(VPR-66、INV-17、GSK-2981278、BBI-6000、その他)、用途別分析(病院、クリニック、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:4SC AG、Celgene Corporation、Aurigene Discovery Technologies Limited、Advinus Therapeutics Ltd.、Bristol-Myers Squibb Company、Arrien Pharmaceuticals, LLC、Genfit SA、Brickell Biotech, Inc.、Biogen, Inc.、Genentech, Inc.、Nuevolution AB、Teijin Pharma Limited、GlaxoSmithKline Plc、Vitae Pharmaceuticals, Inc.、Phenex Pharmaceuticals AG、Lead Pharma Holding B.V.、Hanmi Pharmaceuticals, Co. Ltd.、Visionary Pharmaceuticals, Inc.、Reata Pharmaceuticals, Inc.、Karo Bio AB
・メーカー別販売量、売上、市場シェア
・核内受容体ROR-ガンマの地域別市場分析
・核内受容体ROR-ガンマの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・核内受容体ROR-ガンマのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・核内受容体ROR-ガンマのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・核内受容体ROR-ガンマの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・核内受容体ROR-ガンマの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・核内受容体ROR-ガンマの種類別市場規模2015-2020:VPR-66、INV-17、GSK-2981278、BBI-6000、その他
・核内受容体ROR-ガンマの用途別市場規模2015-2020:病院、クリニック、その他
・核内受容体ROR-ガンマの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global Nuclear Receptor ROR-Gamma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nuclear Receptor ROR-Gamma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nuclear Receptor ROR-Gamma market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nuclear Receptor ROR-Gamma market has been segmented into
VPR-66
INV-17
GSK-2981278
BBI-6000
Others

By Application, Nuclear Receptor ROR-Gamma has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Receptor ROR-Gamma market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Receptor ROR-Gamma markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Receptor ROR-Gamma market.

The report offers in-depth assessment of the growth and other aspects of the Nuclear Receptor ROR-Gamma market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Nuclear Receptor ROR-Gamma Market Share Analysis
Nuclear Receptor ROR-Gamma competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Receptor ROR-Gamma sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Receptor ROR-Gamma sales, revenue and market share for each player covered in this report.

The major players covered in Nuclear Receptor ROR-Gamma are:
4SC AG
Celgene Corporation
Aurigene Discovery Technologies Limited
Advinus Therapeutics Ltd.
Bristol-Myers Squibb Company
Arrien Pharmaceuticals, LLC
Genfit SA
Brickell Biotech, Inc.
Biogen, Inc.
Genentech, Inc.
Nuevolution AB
Teijin Pharma Limited
GlaxoSmithKline Plc
Vitae Pharmaceuticals, Inc.
Phenex Pharmaceuticals AG
Lead Pharma Holding B.V.
Hanmi Pharmaceuticals, Co. Ltd.
Visionary Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Karo Bio AB

Among other players domestic and global, Nuclear Receptor ROR-Gamma market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Receptor ROR-Gamma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Receptor ROR-Gamma, with price, sales, revenue and global market share of Nuclear Receptor ROR-Gamma in 2018 and 2019.
Chapter 3, the Nuclear Receptor ROR-Gamma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Receptor ROR-Gamma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Receptor ROR-Gamma market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Receptor ROR-Gamma sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Nuclear Receptor ROR-Gamma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Nuclear Receptor ROR-Gamma Market
1.4.1 Global Nuclear Receptor ROR-Gamma Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 4SC AG Details
2.1.2 4SC AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 4SC AG SWOT Analysis
2.1.4 4SC AG Product and Services
2.1.5 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celgene Corporation SWOT Analysis
2.2.4 Celgene Corporation Product and Services
2.2.5 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aurigene Discovery Technologies Limited
2.3.1 Aurigene Discovery Technologies Limited Details
2.3.2 Aurigene Discovery Technologies Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aurigene Discovery Technologies Limited SWOT Analysis
2.3.4 Aurigene Discovery Technologies Limited Product and Services
2.3.5 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advinus Therapeutics Ltd.
2.4.1 Advinus Therapeutics Ltd. Details
2.4.2 Advinus Therapeutics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advinus Therapeutics Ltd. SWOT Analysis
2.4.4 Advinus Therapeutics Ltd. Product and Services
2.4.5 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb Company SWOT Analysis
2.5.4 Bristol-Myers Squibb Company Product and Services
2.5.5 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arrien Pharmaceuticals, LLC
2.6.1 Arrien Pharmaceuticals, LLC Details
2.6.2 Arrien Pharmaceuticals, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Arrien Pharmaceuticals, LLC SWOT Analysis
2.6.4 Arrien Pharmaceuticals, LLC Product and Services
2.6.5 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genfit SA
2.7.1 Genfit SA Details
2.7.2 Genfit SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genfit SA SWOT Analysis
2.7.4 Genfit SA Product and Services
2.7.5 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Brickell Biotech, Inc.
2.8.1 Brickell Biotech, Inc. Details
2.8.2 Brickell Biotech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Brickell Biotech, Inc. SWOT Analysis
2.8.4 Brickell Biotech, Inc. Product and Services
2.8.5 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biogen, Inc.
2.9.1 Biogen, Inc. Details
2.9.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biogen, Inc. SWOT Analysis
2.9.4 Biogen, Inc. Product and Services
2.9.5 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech, Inc.
2.10.1 Genentech, Inc. Details
2.10.2 Genentech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genentech, Inc. SWOT Analysis
2.10.4 Genentech, Inc. Product and Services
2.10.5 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Nuevolution AB
2.11.1 Nuevolution AB Details
2.11.2 Nuevolution AB Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Nuevolution AB SWOT Analysis
2.11.4 Nuevolution AB Product and Services
2.11.5 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teijin Pharma Limited
2.12.1 Teijin Pharma Limited Details
2.12.2 Teijin Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teijin Pharma Limited SWOT Analysis
2.12.4 Teijin Pharma Limited Product and Services
2.12.5 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline Plc
2.13.1 GlaxoSmithKline Plc Details
2.13.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline Plc SWOT Analysis
2.13.4 GlaxoSmithKline Plc Product and Services
2.13.5 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Vitae Pharmaceuticals, Inc.
2.14.1 Vitae Pharmaceuticals, Inc. Details
2.14.2 Vitae Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Vitae Pharmaceuticals, Inc. SWOT Analysis
2.14.4 Vitae Pharmaceuticals, Inc. Product and Services
2.14.5 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Phenex Pharmaceuticals AG
2.15.1 Phenex Pharmaceuticals AG Details
2.15.2 Phenex Pharmaceuticals AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Phenex Pharmaceuticals AG SWOT Analysis
2.15.4 Phenex Pharmaceuticals AG Product and Services
2.15.5 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Lead Pharma Holding B.V.
2.16.1 Lead Pharma Holding B.V. Details
2.16.2 Lead Pharma Holding B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Lead Pharma Holding B.V. SWOT Analysis
2.16.4 Lead Pharma Holding B.V. Product and Services
2.16.5 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hanmi Pharmaceuticals, Co. Ltd.
2.17.1 Hanmi Pharmaceuticals, Co. Ltd. Details
2.17.2 Hanmi Pharmaceuticals, Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
2.17.4 Hanmi Pharmaceuticals, Co. Ltd. Product and Services
2.17.5 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Visionary Pharmaceuticals, Inc.
2.18.1 Visionary Pharmaceuticals, Inc. Details
2.18.2 Visionary Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Visionary Pharmaceuticals, Inc. SWOT Analysis
2.18.4 Visionary Pharmaceuticals, Inc. Product and Services
2.18.5 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Reata Pharmaceuticals, Inc.
2.19.1 Reata Pharmaceuticals, Inc. Details
2.19.2 Reata Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Reata Pharmaceuticals, Inc. SWOT Analysis
2.19.4 Reata Pharmaceuticals, Inc. Product and Services
2.19.5 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Karo Bio AB
2.20.1 Karo Bio AB Details
2.20.2 Karo Bio AB Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Karo Bio AB SWOT Analysis
2.20.4 Karo Bio AB Product and Services
2.20.5 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.4 France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.5 India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Receptor ROR-Gamma Price by Type (2015-2020)
11 Global Nuclear Receptor ROR-Gamma Market Segment by Application
11.1 Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Receptor ROR-Gamma Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.2 Europe Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.4 South America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.3 Nuclear Receptor ROR-Gamma Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2021-2025)
12.4 Nuclear Receptor ROR-Gamma Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の核内受容体ROR-ガンマ市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global Nuclear Receptor ROR-Gamma Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。